Global Autoimmune Disease Diagnostics Market Research Report 2024(Status and Outlook)

Global Autoimmune Disease Diagnostics Market Research Report 2024(Status and Outlook)



Report Overview:

The diagnosis of autoimmune diseases depends on the identification of disease-associated clinical symptoms and is associated with the detection of autoantibodies. Clinicians conventionally classify autoimmune diseases as either systemic or organ-specific.

The Global Autoimmune Disease Diagnostics Market Size was estimated at USD 5173.88 million in 2023 and is projected to reach USD 6815.48 million by 2029, exhibiting a CAGR of 4.70% during the forecast period.

This report provides a deep insight into the global Autoimmune Disease Diagnostics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Autoimmune Disease Diagnostics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Autoimmune Disease Diagnostics market in any manner.

Global Autoimmune Disease Diagnostics Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Abbott Laboratories

Beckman Coulter

Bio-Rad Laboratories

EUROIMMUN

Inova Diagnostics

Roche Diagnostics

Siemens Healthcare

DiaSorin

ERBA Diagnostics

Euro Diagnostica

Autoimmune Technologies

Avant Diagnostics

Exagen Diagnostics

Gold Standard Diagnostics

HOB Diagnostics

HUMAN Diagnostics

Immco Diagnostics

ImmunArray

Myriad Genetics

Omega Diagnostics

ORGENTEC Diagnostika

Phadia

Protagen

Market Segmentation (by Type)

Analyzers

Assay Kits

Market Segmentation (by Application)

Hospitals

Research Laboratories

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Autoimmune Disease Diagnostics Market

Overview of the regional outlook of the Autoimmune Disease Diagnostics Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value (USD Billion) data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

Provides insight into the market through Value Chain

Market dynamics scenario, along with growth opportunities of the market in the years to come

Note: this report may need to undergo a final check or review and this could take about 48 hours.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Autoimmune Disease Diagnostics Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Autoimmune Disease Diagnostics
1.2 Key Market Segments
1.2.1 Autoimmune Disease Diagnostics Segment by Type
1.2.2 Autoimmune Disease Diagnostics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Autoimmune Disease Diagnostics Market Overview
2.1 Global Market Overview
2.1.1 Global Autoimmune Disease Diagnostics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Autoimmune Disease Diagnostics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Autoimmune Disease Diagnostics Market Competitive Landscape
3.1 Global Autoimmune Disease Diagnostics Sales by Manufacturers (2019-2024)
3.2 Global Autoimmune Disease Diagnostics Revenue Market Share by Manufacturers (2019-2024)
3.3 Autoimmune Disease Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Autoimmune Disease Diagnostics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Autoimmune Disease Diagnostics Sales Sites, Area Served, Product Type
3.6 Autoimmune Disease Diagnostics Market Competitive Situation and Trends
3.6.1 Autoimmune Disease Diagnostics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Autoimmune Disease Diagnostics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Autoimmune Disease Diagnostics Industry Chain Analysis
4.1 Autoimmune Disease Diagnostics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Autoimmune Disease Diagnostics Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Autoimmune Disease Diagnostics Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Autoimmune Disease Diagnostics Sales Market Share by Type (2019-2024)
6.3 Global Autoimmune Disease Diagnostics Market Size Market Share by Type (2019-2024)
6.4 Global Autoimmune Disease Diagnostics Price by Type (2019-2024)
7 Autoimmune Disease Diagnostics Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Autoimmune Disease Diagnostics Market Sales by Application (2019-2024)
7.3 Global Autoimmune Disease Diagnostics Market Size (M USD) by Application (2019-2024)
7.4 Global Autoimmune Disease Diagnostics Sales Growth Rate by Application (2019-2024)
8 Autoimmune Disease Diagnostics Market Segmentation by Region
8.1 Global Autoimmune Disease Diagnostics Sales by Region
8.1.1 Global Autoimmune Disease Diagnostics Sales by Region
8.1.2 Global Autoimmune Disease Diagnostics Sales Market Share by Region
8.2 North America
8.2.1 North America Autoimmune Disease Diagnostics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Autoimmune Disease Diagnostics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Autoimmune Disease Diagnostics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Autoimmune Disease Diagnostics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Autoimmune Disease Diagnostics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Abbott Laboratories
9.1.1 Abbott Laboratories Autoimmune Disease Diagnostics Basic Information
9.1.2 Abbott Laboratories Autoimmune Disease Diagnostics Product Overview
9.1.3 Abbott Laboratories Autoimmune Disease Diagnostics Product Market Performance
9.1.4 Abbott Laboratories Business Overview
9.1.5 Abbott Laboratories Autoimmune Disease Diagnostics SWOT Analysis
9.1.6 Abbott Laboratories Recent Developments
9.2 Beckman Coulter
9.2.1 Beckman Coulter Autoimmune Disease Diagnostics Basic Information
9.2.2 Beckman Coulter Autoimmune Disease Diagnostics Product Overview
9.2.3 Beckman Coulter Autoimmune Disease Diagnostics Product Market Performance
9.2.4 Beckman Coulter Business Overview
9.2.5 Beckman Coulter Autoimmune Disease Diagnostics SWOT Analysis
9.2.6 Beckman Coulter Recent Developments
9.3 Bio-Rad Laboratories
9.3.1 Bio-Rad Laboratories Autoimmune Disease Diagnostics Basic Information
9.3.2 Bio-Rad Laboratories Autoimmune Disease Diagnostics Product Overview
9.3.3 Bio-Rad Laboratories Autoimmune Disease Diagnostics Product Market Performance
9.3.4 Bio-Rad Laboratories Autoimmune Disease Diagnostics SWOT Analysis
9.3.5 Bio-Rad Laboratories Business Overview
9.3.6 Bio-Rad Laboratories Recent Developments
9.4 EUROIMMUN
9.4.1 EUROIMMUN Autoimmune Disease Diagnostics Basic Information
9.4.2 EUROIMMUN Autoimmune Disease Diagnostics Product Overview
9.4.3 EUROIMMUN Autoimmune Disease Diagnostics Product Market Performance
9.4.4 EUROIMMUN Business Overview
9.4.5 EUROIMMUN Recent Developments
9.5 Inova Diagnostics
9.5.1 Inova Diagnostics Autoimmune Disease Diagnostics Basic Information
9.5.2 Inova Diagnostics Autoimmune Disease Diagnostics Product Overview
9.5.3 Inova Diagnostics Autoimmune Disease Diagnostics Product Market Performance
9.5.4 Inova Diagnostics Business Overview
9.5.5 Inova Diagnostics Recent Developments
9.6 Roche Diagnostics
9.6.1 Roche Diagnostics Autoimmune Disease Diagnostics Basic Information
9.6.2 Roche Diagnostics Autoimmune Disease Diagnostics Product Overview
9.6.3 Roche Diagnostics Autoimmune Disease Diagnostics Product Market Performance
9.6.4 Roche Diagnostics Business Overview
9.6.5 Roche Diagnostics Recent Developments
9.7 Siemens Healthcare
9.7.1 Siemens Healthcare Autoimmune Disease Diagnostics Basic Information
9.7.2 Siemens Healthcare Autoimmune Disease Diagnostics Product Overview
9.7.3 Siemens Healthcare Autoimmune Disease Diagnostics Product Market Performance
9.7.4 Siemens Healthcare Business Overview
9.7.5 Siemens Healthcare Recent Developments
9.8 DiaSorin
9.8.1 DiaSorin Autoimmune Disease Diagnostics Basic Information
9.8.2 DiaSorin Autoimmune Disease Diagnostics Product Overview
9.8.3 DiaSorin Autoimmune Disease Diagnostics Product Market Performance
9.8.4 DiaSorin Business Overview
9.8.5 DiaSorin Recent Developments
9.9 ERBA Diagnostics
9.9.1 ERBA Diagnostics Autoimmune Disease Diagnostics Basic Information
9.9.2 ERBA Diagnostics Autoimmune Disease Diagnostics Product Overview
9.9.3 ERBA Diagnostics Autoimmune Disease Diagnostics Product Market Performance
9.9.4 ERBA Diagnostics Business Overview
9.9.5 ERBA Diagnostics Recent Developments
9.10 Euro Diagnostica
9.10.1 Euro Diagnostica Autoimmune Disease Diagnostics Basic Information
9.10.2 Euro Diagnostica Autoimmune Disease Diagnostics Product Overview
9.10.3 Euro Diagnostica Autoimmune Disease Diagnostics Product Market Performance
9.10.4 Euro Diagnostica Business Overview
9.10.5 Euro Diagnostica Recent Developments
9.11 Autoimmune Technologies
9.11.1 Autoimmune Technologies Autoimmune Disease Diagnostics Basic Information
9.11.2 Autoimmune Technologies Autoimmune Disease Diagnostics Product Overview
9.11.3 Autoimmune Technologies Autoimmune Disease Diagnostics Product Market Performance
9.11.4 Autoimmune Technologies Business Overview
9.11.5 Autoimmune Technologies Recent Developments
9.12 Avant Diagnostics
9.12.1 Avant Diagnostics Autoimmune Disease Diagnostics Basic Information
9.12.2 Avant Diagnostics Autoimmune Disease Diagnostics Product Overview
9.12.3 Avant Diagnostics Autoimmune Disease Diagnostics Product Market Performance
9.12.4 Avant Diagnostics Business Overview
9.12.5 Avant Diagnostics Recent Developments
9.13 Exagen Diagnostics
9.13.1 Exagen Diagnostics Autoimmune Disease Diagnostics Basic Information
9.13.2 Exagen Diagnostics Autoimmune Disease Diagnostics Product Overview
9.13.3 Exagen Diagnostics Autoimmune Disease Diagnostics Product Market Performance
9.13.4 Exagen Diagnostics Business Overview
9.13.5 Exagen Diagnostics Recent Developments
9.14 Gold Standard Diagnostics
9.14.1 Gold Standard Diagnostics Autoimmune Disease Diagnostics Basic Information
9.14.2 Gold Standard Diagnostics Autoimmune Disease Diagnostics Product Overview
9.14.3 Gold Standard Diagnostics Autoimmune Disease Diagnostics Product Market Performance
9.14.4 Gold Standard Diagnostics Business Overview
9.14.5 Gold Standard Diagnostics Recent Developments
9.15 HOB Diagnostics
9.15.1 HOB Diagnostics Autoimmune Disease Diagnostics Basic Information
9.15.2 HOB Diagnostics Autoimmune Disease Diagnostics Product Overview
9.15.3 HOB Diagnostics Autoimmune Disease Diagnostics Product Market Performance
9.15.4 HOB Diagnostics Business Overview
9.15.5 HOB Diagnostics Recent Developments
9.16 HUMAN Diagnostics
9.16.1 HUMAN Diagnostics Autoimmune Disease Diagnostics Basic Information
9.16.2 HUMAN Diagnostics Autoimmune Disease Diagnostics Product Overview
9.16.3 HUMAN Diagnostics Autoimmune Disease Diagnostics Product Market Performance
9.16.4 HUMAN Diagnostics Business Overview
9.16.5 HUMAN Diagnostics Recent Developments
9.17 Immco Diagnostics
9.17.1 Immco Diagnostics Autoimmune Disease Diagnostics Basic Information
9.17.2 Immco Diagnostics Autoimmune Disease Diagnostics Product Overview
9.17.3 Immco Diagnostics Autoimmune Disease Diagnostics Product Market Performance
9.17.4 Immco Diagnostics Business Overview
9.17.5 Immco Diagnostics Recent Developments
9.18 ImmunArray
9.18.1 ImmunArray Autoimmune Disease Diagnostics Basic Information
9.18.2 ImmunArray Autoimmune Disease Diagnostics Product Overview
9.18.3 ImmunArray Autoimmune Disease Diagnostics Product Market Performance
9.18.4 ImmunArray Business Overview
9.18.5 ImmunArray Recent Developments
9.19 Myriad Genetics
9.19.1 Myriad Genetics Autoimmune Disease Diagnostics Basic Information
9.19.2 Myriad Genetics Autoimmune Disease Diagnostics Product Overview
9.19.3 Myriad Genetics Autoimmune Disease Diagnostics Product Market Performance
9.19.4 Myriad Genetics Business Overview
9.19.5 Myriad Genetics Recent Developments
9.20 Omega Diagnostics
9.20.1 Omega Diagnostics Autoimmune Disease Diagnostics Basic Information
9.20.2 Omega Diagnostics Autoimmune Disease Diagnostics Product Overview
9.20.3 Omega Diagnostics Autoimmune Disease Diagnostics Product Market Performance
9.20.4 Omega Diagnostics Business Overview
9.20.5 Omega Diagnostics Recent Developments
9.21 ORGENTEC Diagnostika
9.21.1 ORGENTEC Diagnostika Autoimmune Disease Diagnostics Basic Information
9.21.2 ORGENTEC Diagnostika Autoimmune Disease Diagnostics Product Overview
9.21.3 ORGENTEC Diagnostika Autoimmune Disease Diagnostics Product Market Performance
9.21.4 ORGENTEC Diagnostika Business Overview
9.21.5 ORGENTEC Diagnostika Recent Developments
9.22 Phadia
9.22.1 Phadia Autoimmune Disease Diagnostics Basic Information
9.22.2 Phadia Autoimmune Disease Diagnostics Product Overview
9.22.3 Phadia Autoimmune Disease Diagnostics Product Market Performance
9.22.4 Phadia Business Overview
9.22.5 Phadia Recent Developments
9.23 Protagen
9.23.1 Protagen Autoimmune Disease Diagnostics Basic Information
9.23.2 Protagen Autoimmune Disease Diagnostics Product Overview
9.23.3 Protagen Autoimmune Disease Diagnostics Product Market Performance
9.23.4 Protagen Business Overview
9.23.5 Protagen Recent Developments
10 Autoimmune Disease Diagnostics Market Forecast by Region
10.1 Global Autoimmune Disease Diagnostics Market Size Forecast
10.2 Global Autoimmune Disease Diagnostics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Autoimmune Disease Diagnostics Market Size Forecast by Country
10.2.3 Asia Pacific Autoimmune Disease Diagnostics Market Size Forecast by Region
10.2.4 South America Autoimmune Disease Diagnostics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Autoimmune Disease Diagnostics by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Autoimmune Disease Diagnostics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Autoimmune Disease Diagnostics by Type (2025-2030)
11.1.2 Global Autoimmune Disease Diagnostics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Autoimmune Disease Diagnostics by Type (2025-2030)
11.2 Global Autoimmune Disease Diagnostics Market Forecast by Application (2025-2030)
11.2.1 Global Autoimmune Disease Diagnostics Sales (Kilotons) Forecast by Application
11.2.2 Global Autoimmune Disease Diagnostics Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings